Nanobody‐based heavy chain antibodies and chimeric antibodies
Immunological Reviews · 2024
DOI: 10.1111/imr.13385 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, 2024. Verfasst von Friedrich Koch-Nolte. Beteiligte Einrichtung: Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Immunoglobulin Heavy Chains, Single-Domain Antibodies. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe, Wilhelm Sander-Stiftung.
Abstract (Originalsprache)
Nanobodies are the products of an intriguing invention in the evolution of immunoglobulins. This invention can be traced back approximately 45 million years to the common ancestor of extant dromedaries, camels, llamas, and alpacas. Next to conventional heterotetrameric H2L2 antibodies, these camelids produce homodimeric nanobody‐based heavy chain antibodies, composed of shortened heavy chains that a lack the CH1 domain. Nanobodies against human target antigens are derived from immunized animals and/or synthetic nanobody libraries. As a robust, highly soluble, single immunoglobulin domain, a nanobody can easily be fused to another protein, for example to another nanobody and/or the hinge and constant domains of other immunoglobulins. Nanobody‐derived heavy chain antibodies hold promise as a new form of immunotherapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
ORCID-Profile: Friedrich Koch-Nolte
Förderung
- Deutsche Forschungsgemeinschaft
- Deutsche Krebshilfe
- Wilhelm Sander-Stiftung
- José Carreras Leukämie-Stiftung
- Bundesministerium für Bildung und Forschung
- Werner Otto Stiftung
- Hamburger Krebsgesellschaft
- European Cooperation in Science and Technology
Zitieren
APA
Koch-Nolte, F. (2024). Nanobody‐based heavy chain antibodies and chimeric antibodies. Immunological Reviews. https://doi.org/10.1111/imr.13385
Vancouver
Koch-Nolte F. Nanobody‐based heavy chain antibodies and chimeric antibodies. Immunological Reviews. 2024. doi:10.1111/imr.13385
BibTeX
@article{KochNolte2024,
author = {Koch-Nolte, Friedrich},
title = {Nanobody‐based heavy chain antibodies and chimeric antibodies},
journal = {Immunological Reviews},
year = {2024},
doi = {10.1111/imr.13385}
}
EUVIMED